2020
DOI: 10.1021/acschemneuro.9b00549
|View full text |Cite
|
Sign up to set email alerts
|

Innovative IgG Biomarkers Based on Phage Display Microbial Amyloid Mimotope for State and Stage Diagnosis in Alzheimer’s Disease

Abstract: An innovative approach to identify new conformational antigens of Aβ 1–42 recognized by IgG autoantibodies as biomarkers of state and stage in Alzheimer’s disease (AD) patients is described. In particular, through the use of bioinformatics modeling, conformational similarities between several Aβ 1–42 forms and other amyloid-like proteins with F1 capsular antigen (Caf1) of Yersinia pestis were first found. pVIII M13 phage display libraries wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
10

Relationship

6
4

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 74 publications
0
18
0
Order By: Relevance
“…In 2020, Plano et al . performed a double binding phage display selection to identify new conformation antigens of Aβ 1-42 by alternating biopanning with AD serum and monoclonal antibody YPF19 (chosen as like Aβ-amyloid structure protein), which can be used as novel diagnostic biomarkers for the diagnosis of AD patients 111 . Compared with wild-type phage M13, the selected recombinant phage clone 12III1 showed a greater ability to prevent amyloid aggregation and promote disaggregation of preformed fibrils 112 .…”
Section: Phage Display Technology For Ad Early Diagnosismentioning
confidence: 99%
“…In 2020, Plano et al . performed a double binding phage display selection to identify new conformation antigens of Aβ 1-42 by alternating biopanning with AD serum and monoclonal antibody YPF19 (chosen as like Aβ-amyloid structure protein), which can be used as novel diagnostic biomarkers for the diagnosis of AD patients 111 . Compared with wild-type phage M13, the selected recombinant phage clone 12III1 showed a greater ability to prevent amyloid aggregation and promote disaggregation of preformed fibrils 112 .…”
Section: Phage Display Technology For Ad Early Diagnosismentioning
confidence: 99%
“…pC89 (M13 wild-type vector without peptide insert) and two engineered phage clones with different amino acid sequences of the foreign peptide were used. Specifically, the P9b phage clone displayed the sequence QRKLAAKLT [41], while the 12III1 the sequence RWPPHFEWHFDD [42]. Propagation of pC89 and engineered phage clones was carried out in Escherichia coli TG1 bacterial host (Lac-Z deleted).…”
Section: Bacteriophagesmentioning
confidence: 99%
“…In addition, 12III1 phage clone was obtained by screening of 12-mer phage library against anti-Caf1 monoclonal antibody and IgGs from AD-patients, in alternate biopanning cycles, named "double binding" selection. 12III1 display the 12 amino acid sequence, RWPPHFEWHFDD, able to detect IgG levels correlated with Alzheimer disease [34]. All radiation tests were carried out using the insert-less pC89 vector as wild-type virus variant.…”
Section: Bacteriophagesmentioning
confidence: 99%